TCR signal transduction: Opening the black box

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 4821-4827

  Weiss, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; LAT PROTEIN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; RAC PROTEIN; RAS PROTEIN; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; ENZYME ACTIVATION; HUMAN; IMMUNE SYSTEM; LEUKEMIA CELL LINE; MEDICAL PROFESSION; NONHUMAN; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROTEIN FUNCTION; PROTEIN STRUCTURE; RHEUMATIC DISEASE; SIGNAL TRANSDUCTION; SOMATIC CELL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, CD45; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 77954139684     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0990083     Document Type: Conference Paper

References (61)

1. Allison, J. P., B. W. McIntyre, and D. Bloch. 1982. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. J. Immunol. 129: 2293-2300. (Pubitemid 12004412)
2. Haskins, K., R. Kubo, J. White, M. Pigeon, J. Kappler, and P. Marrack. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157: 1149-1169. (Pubitemid 13083697)
3. Meuer, S. C., K. A. Fitzgerald, R. E. Hussey, J. C. Hodgdon, S. F. Schlossman, and E. L. Reinherz. 1983. Clonotypic structures involved in antigen-specific human T cell function: relationship to the T3 molecular complex. J. Exp. Med. 157: 705-719.
4. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol. 133: 123-128. (Pubitemid 14076697)
5. Koretzky, G. A., R. P. Daniele, W. C. Greene, and P. C. Nowell. 1983. Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc. Natl. Acad. Sci. USA 80: 3444-3447. (Pubitemid 13060179)
6. Tsien, R. Y., T. Pozzan, and T. J. Rink. 1982. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J. Cell Biol. 94: 325-334.
7. Weiss, A., J. Imboden, D. Shoback, and J. Stobo. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 81: 4169-4173. (Pubitemid 14054542)
8. Imboden, J. B., A. Weiss, and J. D. Stobo. 1985. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J. Immunol. 134: 663-665.
9. Imboden, J. B., and J. D. Stobo. 1985. Transmembrane signalling by the T cell antigen receptor: perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161: 446-456.
10. Weiss, A., G. Koretzky, R. C. Schatzman, and T. Kadlecek. 1991. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-γ1. Proc. Natl. Acad. Sci. USA 88: 5484-5488. (Pubitemid 21914769)
11. Weiss, A., and J. D. Stobo. 1984. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med. 160: 1284-1299.
12. Ohashi, P. S., T. W. Mak, P. Van den Elsen, Y. Yanagi, Y. Yoshikai, A. F. Calman, C. Terhorst, J. D. Stobo, and A. Weiss. 1985. Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature 316: 606-609.
13. Morley, B. J., K. N. Chin, M. E. Newton, and A. Weiss. 1988. The lysine residue in the membrane-spanning domain of the β chain is necessary for cell surface expression of the T cell antigen receptor. J. Exp. Med. 168: 1971-1978.
14. Tan, L., J. Turner, and A. Weiss. 1991. Regions of the T cell receptor α and β chains that are responsible for interactions with CD3. J. Exp. Med. 173: 1247-1256.
15. Mercep, M., J. S. Bonifacino, P. Garcia-Morales, L. E. Samelson, R. D. Klausner, and J. D. Ashwell. 1988. T cell CD3-ζη heterodimer expression and coupling to phosphoinositide hydrolysis. Science 242: 571-574.
16. Irving, B. A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64: 891-901.
17. Romeo, C., and B. Seed. 1991. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64: 1037-1046.
18. Wegener, A. M., F. Letourneur, A. Hoeveler, T. Brocker, F. Luton, and B. Malissen. 1992. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68: 83-95.
19. Cambier, J. C. 1995. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL). Immunol. Today 16: 110.
20. Goldsmith, M. A., P. F. Dazin, and A. Weiss. 1988. At least two non-antigenbinding molecules are required for signal transduction by the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 85: 8613-8617.
21. Goldsmith, M. A., D. M. Desai, T. Schultz, and A. Weiss. 1989. Function of a heterologous muscarinic receptor in T cell antigen receptor signal transduction mutants. J. Biol. Chem. 264: 17190-17197.
22. Goldsmith, M. A., and A. Weiss. 1987. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. USA 84: 6879-6883.
23. June, C. H., M. C. Fletcher, J. A. Ledbetter, and L. E. Samelson. 1990. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144: 1591-1599.
24. June, C. H., M. C. Fletcher, J. A. Ledbetter, G. L. Schieven, J. N. Siegel, A. F. Phillips, and L. E. Samelson. 1990. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 87: 7722-7726.
25. Weissman, A. M., P. Ross, E. T. Luong, P. Garcia-Morales, M. L. Jelachich, W. E. Biddison, R. D. Klausner, and L. E. Samelson. 1988. Tyrosine phosphorylation of the human T cell antigen receptor ζ-chain: activation via CD3 but not CD2. J. Immunol. 141: 3532-3536.
26. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593.
27. van Oers, N. S., N. Killeen, and A. Weiss. 1996. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 183: 1053-1062.
28. Weiss, A. 1993. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73: 209-212.
29. Chan, A. C., T. A. Kadlecek, M. E. Elder, A. H. Filipovich, W. L. Kuo, M. Iwashima, T. G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264: 1599-1601.
30. Elder, M. E., D. Lin, J. Clever, A. C. Chan, T. J. Hope, A. Weiss, and T. G. Parslow. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264: 1596-1599.
31. + thymic selection in humans lacking ZAP-70 kinase. Cell 76: 947-958.
32. Elder, M. E., S. Skoda-Smith, T. A. Kadlecek, F. Wang, J. Wu, and A. Weiss. 2001. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J. Immunol. 166: 656-661.
33. Kadlecek, T. A., N. S. van Oers, L. Lefrancois, S. Olson, D. Finlay, D. H. Chu, K. Connolly, N. Killeen, and A. Weiss. 1998. Differential requirements for ZAP-70 in TCR signaling and T cell development. J. Immunol. 161: 4688-4694.
34. Negishi, I., N. Motoyama, K. Nakayama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang, A. C. Chan, and D. Y. Loh. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376: 435-438.
35. Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426: 454-460.
36. Siggs, O. M., L. A. Miosge, A. L. Yates, E. M. Kucharska, D. Sheahan, T. Brdicka, A. Weiss, A. Liston, and C. C. Goodnow. 2007. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27: 912-926.
37. Schweighoffer, E., L. Vanes, A. Mathiot, T. Nakamura, and V. L. Tybulewicz. 2003. Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. Immunity 18: 523-533.
38. Rassenti, L. Z., L. Huynh, T. L. Toy, L. Chen, M. J. Keating, J. G. Gribben, D. S. Neuberg, I. W. Flinn, K. R. Rai, J. C. Byrd, et al. 2004. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl. J. Med. 351: 893-901.
39. Chen, L., J. Apgar, L. Huynh, F. Dicker, T. Giago-McGahan, L. Rassenti, A. Weiss, and T. J. Kipps. 2005. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 105: 2036-2041.
40. Williams, B. L., K. L. Schreiber, W. Zhang, R. L. Wange, L. E. Samelson, P. J. Leibson, and R. T. Abraham. 1998. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell Biol. 18: 1388-1399.
41. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92: 83-92.
42. Fang, N., D. G. Motto, S. E. Ross, and G. A. Koretzky. 1996. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J. Immunol. 157: 3769-3773. (Pubitemid 126449281)
43. Motto, D. G., S. E. Ross, J. Wu, L. R. Hendricks-Taylor, and G. A. Koretzky. 1996. Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J. Exp. Med. 183: 1937-1943.
44. Finco, T. S., T. Kadlecek, W. Zhang, L. E. Samelson, and A. Weiss. 1998. LAT is required for TCR-mediated activation of PLCγ1 and the Ras pathway. Immunity 9: 617-626.
45. Ku, G. M., D. Yablonski, E. Manser, L. Lim, and A. Weiss. 2001. A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT. The EMBO J. 20: 457-465.
46. Lin, J., and A. Weiss. 2001. Identification of the minimal tyrosine residues required for linker for activation of T cell function. J. Biol. Chem. 276: 29588-29595. (Pubitemid 37452058)
47. Liou, J., F. Kiefer, A. Dang, A. Hashimoto, M. H. Cobb, T. Kurosaki, and A. Weiss. 2000. HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 12: 399-408.
48. Yablonski, D., M. R. Kuhne, T. Kadlecek, and A. Weiss. 1998. Uncoupling of nonreceptor tyrosine kinases from PLC-γ1 in an SLP-76-deficient T cell. Science 281: 413-416.
49. Zhao, Q., B. L. Williams, R. T. Abraham, and A. Weiss. 1999. Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes. Mol. Cell Biol. 19: 948-956.
50. Brdicka, T., T. A. Kadlecek, J. P. Roose, A. W. Pastuszak, and A. Weiss. 2005. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases. Mol. Cell Biol. 25: 4924-4933.
51. Deindl, S., T. A. Kadlecek, T. Brdicka, X. Cao, A. Weiss, and J. Kuriyan. 2007. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell 129: 735-746.
52. Shah, K., Y. Liu, C. Deirmengian, and K. M. Shokat. 1997. Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc. Natl. Acad. Sci. USA 94: 3565-3570.
53. Levin, S. E., C. Zhang, T. A. Kadlecek, K. M. Shokat, and A. Weiss. 2008. Inhibition of ZAP-70 kinase activity via an analog-sensitive allele blocks T cell receptor and CD28 superagonist signaling. J. Biol. Chem. 283: 15419-15430.
54. Hermiston, M. L., Z. Xu, and A. Weiss. 2003. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21: 107-137.
55. Koretzky, G. A., J. Picus, T. Schultz, and A. Weiss. 1991. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA 88: 2037-2041.
56. Koretzky, G. A., J. Picus, M. L. Thomas, and A. Weiss. 1990. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 346: 66-68.
57. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103: 1059-1070.
58. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3: 764-771.
59. Hermiston, M. L., J. Zikherman, A. L. Tan, V. C. Lam, N. M. Cresalia, N. Oksenberg, N. Goren, D. Brassat, J. R. Oksenberg, and A. Weiss. 2009. Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses. Proc. Natl. Acad. Sci. USA 106: 546-551.
60. Cao, Y., E. M. Janssen, A. W. Duncan, A. Altman, D. D. Billadeau, and R. T. Abraham. 2002. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J. 21: 4809-4819.
61. Roose, J. P., M. Mollenauer, V. A. Gupta, J. Stone, and A. Weiss. 2005. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol. Cell Biol. 25: 4426-4441.